OGT, a global provider of genomic research and diagnostic solutions, announces the opening of state-of-the-art facilities within the Oxford Technology Park.
The move represents a multi-million-pound investment, fuelled by company growth and growing customer demand.
"This is an exciting time of growth and development for us. We are thrilled to celebrate the opening of our advanced facility in the heart of the Oxford innovation quarter," said Adrian Smith, CEO of OGT.
"From here, we can accelerate our next phase of product development and global expansion – providing our customers with greater access to leading-class products and tailored solutions backed by extensive collaboration and support."
Customers will benefit from face-to-face support with OGT's field application specialists within the new show lab as a novel service.
Here, the scientific team can give in-depth demonstrations for both NGS and FISH products.
Designed in collaboration with recognised cancer experts, OGT’s SureSeq NGS panels offer good coverage and uniformity, allowing accurate detection of key genetic aberrations in a wide range of haematological and solid tumour cancers.
By collaborating closely with customers, OGT can help to progress the future of genetic-based medicine, providing comprehensive solutions tailored to the unique needs of its diverse customer base.
Investment Minister, Lord Dominic Johnson also commented on OGT’s expansion: “I am delighted that this larger site at the Oxford Technology Park will grow to bring together the best of investment and expertise, making the most of what the UK has to offer.”
